Design, synthesis and biological evaluation of (E)-2-(2-arylhydrazinyl)quinoxalines, a promising and potent new class of anticancer agents
Authors: Rodrigues, F.A.R.; Bomfim, I.S.; Cavalcanti, B.C.; Pessoa, C.O.; Wardell, J.L.; Wardell, S.M.S.V.; Pinheiro, A.C.; Kaiser, C.R.; Nogueira, T.C.M.; Low, J.N.; Gomes, L.R.; De Souza, M.V.N. Source: Bioorganic & Medicinal Chemistry Letters (Print), v. 24, p. 934-939, 2014. Publisher: Elsevier Abstract A series of forty-seven quinoxaline derivatives, 2-(XYZC6H2CHN–NH)-quinoxalines, 1, have been synthesized and […]
